Advertisement
In DepthInfectious Diseases

New coronavirus threat galvanizes scientists

Science31 Jan 2020Vol 367, Issue 6477pp. 492-493DOI: 10.1126/science.367.6477.492
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Information & Authors

Information

Published In

Science
Volume 367Issue 647731 January 2020
Pages: 492 - 493

Permissions

Request permissions for this article.

Authors

Affiliations

Metrics & Citations

Metrics

Citations

View Options

Media

Figures

Other

Tables

Share

Information & Authors
Published In
issue cover image
Science
Volume 367|Issue 6477
31 January 2020
Submission history
Published in print:31 January 2020
Metrics & Citations
Article usage
Altmetrics
Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. Immune response scenario and vaccine development for SARS-CoV-2 infection, International Immunopharmacology, 94, (107439), (2021).https://doi.org/10.1016/j.intimp.2021.107439
    Crossref
  2. Large-scale genome sequencing reveals the driving forces of viruses in microalgal evolution, Cell Host & Microbe, 29, 2, (250-266.e8), (2021).https://doi.org/10.1016/j.chom.2020.12.005
    Crossref
  3. A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review, Frontiers in Pharmacology, 11, (2021).https://doi.org/10.3389/fphar.2020.590154
    Crossref
  4. Sociocultural, behavioural and political factors shaping the COVID-19 pandemic: the need for a biocultural approach to understanding pandemics and (re)emerging pathogens, Global Public Health, 16, 1, (17-35), (2020).https://doi.org/10.1080/17441692.2020.1828982
    Crossref
  5. Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review, Journal of Medical Virology, 93, 1, (275-299), (2020).https://doi.org/10.1002/jmv.26254
    Crossref
  6. SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations, VirusDisease, 31, 4, (411-423), (2020).https://doi.org/10.1007/s13337-020-00632-9
    Crossref
  7. Going global – Travel and the 2019 novel coronavirus, Travel Medicine and Infectious Disease, 33, (101578), (2020).https://doi.org/10.1016/j.tmaid.2020.101578
    Crossref
  8. Research Progress of Drug Treatment in Novel Coronavirus Pneumonia, AAPS PharmSciTech, 21, 4, (2020).https://doi.org/10.1208/s12249-020-01679-z
    Crossref
  9. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses, Infection, Genetics and Evolution, 85, (104502), (2020).https://doi.org/10.1016/j.meegid.2020.104502
    Crossref
  10. Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment, AIMS Microbiology, 7, 3, (183-203), (2020).https://doi.org/10.3934/microbiol.2020013
    Crossref
  11. See more
Loading...
Share
Share article link

Share on social media
Get Access
Log in to view the full text

AAAS Log in

AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions, as well as limited access for those who register for access.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View Options
Tables
References

(0)eLetters

No eLetters have been published for this article yet.

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.